PE20080234A1 - Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas - Google Patents
Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidasInfo
- Publication number
- PE20080234A1 PE20080234A1 PE2007000616A PE2007000616A PE20080234A1 PE 20080234 A1 PE20080234 A1 PE 20080234A1 PE 2007000616 A PE2007000616 A PE 2007000616A PE 2007000616 A PE2007000616 A PE 2007000616A PE 20080234 A1 PE20080234 A1 PE 20080234A1
- Authority
- PE
- Peru
- Prior art keywords
- sulfamide
- methyl
- benzoheteroarylsulfamides
- antiepileptic
- derivatives
- Prior art date
Links
- 239000001961 anticonvulsive agent Substances 0.000 title abstract 2
- 230000003556 anti-epileptic effect Effects 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 abstract 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 abstract 1
- 229960000623 carbamazepine Drugs 0.000 abstract 1
- CXOXHMZGEKVPMT-UHFFFAOYSA-N clobazam Chemical compound O=C1CC(=O)N(C)C2=CC=C(Cl)C=C2N1C1=CC=CC=C1 CXOXHMZGEKVPMT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001403 clobazam Drugs 0.000 abstract 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 abstract 1
- 229960003120 clonazepam Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 229960002870 gabapentin Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229960002036 phenytoin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
REFERIDA A UN DERIVADO DE BENZOHETEROARILSULFAMIDA DE FORMULA (I), DONDE R1 ES H, HALOGENO, OH, METOXI, NITRO, ENTRE OTROS; X-Y ES -S-CH-, -O-CH-, -O-C(CH3)-, ENTRE OTROS; A ES -CH2- O -CH(CH3)-; R2 ES H O METILO; R3 Y R4 SON H O ALQUILO C1-C4 O JUNTO CON EL ATOMO DE NITROGENO AL CUAL ESTAN UNIDOS FORMAN UN ANILLO DE 5 A 7 MIEMBROS OPCIONALMENTE SUSTITUIDO CON O, N O S. SON COMPUESTOS PREFERIDOS: N-(BENZO[b]TIEN-3-ILMETIL)-SULFAMIDA, N-[(5-CLOROBENZO[b]TIEN-3-IL)METIL]-SULFAMIDA, N-[(5-FLUOROBENZO[b]TIEN-3-IL)METIL]-SULFAMIDA, ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LA EPILEPSIA Y TRASTORNOS RELACIONADOS. TAMBIEN ESTA REFERIDA A UNA COMBINACION FARMACEUTICA QUE COMPRENDE LOS COMPUESTOS DE FORMULA (I) Y OTRO AGENTE ANTIEPILEPTICO TAL COMO CARBAMAZEPINA, CLOBAZAM, CLONAZEPAM, GABAPENTINA, FENITOINA, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80200106P | 2006-05-19 | 2006-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080234A1 true PE20080234A1 (es) | 2008-04-25 |
Family
ID=38510389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000616A PE20080234A1 (es) | 2006-05-19 | 2007-05-21 | Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070293476A1 (es) |
| AR (1) | AR061066A1 (es) |
| CL (1) | CL2007001468A1 (es) |
| PE (1) | PE20080234A1 (es) |
| TW (1) | TW200812574A (es) |
| UY (1) | UY30360A1 (es) |
| WO (1) | WO2007137164A2 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| EA200702558A1 (ru) * | 2005-05-20 | 2008-06-30 | Янссен Фармацевтика Н. В. | Способ получения производных сульфамида |
| US8937096B2 (en) * | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| US20070155827A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| US8497298B2 (en) * | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| US8716231B2 (en) * | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US8691867B2 (en) * | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| US20070155823A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| AR058389A1 (es) * | 2005-12-19 | 2008-01-30 | Janssen Pharmaceutica Nv | Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad |
| US20070191474A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine |
| AU2007253814A1 (en) * | 2006-05-19 | 2007-11-29 | Janssen Pharmaceutica N.V. | Co-therapy for the treatment of epilepsy |
| MX2008016000A (es) * | 2006-06-15 | 2009-03-05 | Sanol Arznei Schwarz Gmbh | Composicion farmaceutica con efecto anticonvulsivante sinergistico. |
| US20090247616A1 (en) * | 2008-03-26 | 2009-10-01 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety |
| US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
| CA2729056A1 (en) | 2008-06-23 | 2010-01-21 | Janssen Pharmaceutica Nv | Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| WO2016044370A1 (en) | 2014-09-16 | 2016-03-24 | India Globalization Capital, Inc. | Cannabinoid composition and method for treating pain |
| CA2974895A1 (en) | 2015-01-25 | 2016-07-28 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
| US10596159B2 (en) | 2015-08-12 | 2020-03-24 | India Globalization Capital, Inc. | Method and composition for treating cachexia and eating disorders |
| WO2017218629A1 (en) | 2016-06-15 | 2017-12-21 | India Globalization Capital, Inc. | Method and composition for treating seizure disorders |
| CN111801096B (zh) | 2018-03-20 | 2024-03-05 | 卫材R&D管理有限公司 | 癫痫治疗剂 |
| WO2024054807A1 (en) * | 2022-09-06 | 2024-03-14 | Biohaven Therapeutics Ltd. | Combination therapies including metal channel activators and tdp-43 modulators |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| WO1997019682A1 (en) * | 1995-12-01 | 1997-06-05 | Synaptic Pharmaceutical Corporation | Aryl sulfonamide and sulfamide derivatives and uses thereof |
| AU782759B2 (en) * | 1999-08-20 | 2005-08-25 | Ortho-Mcneil Pharmaceutical, Inc. | Composition comprising a tramadol material and an anticonvulsant drug |
| CN1897950A (zh) * | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
| EP1727538A2 (en) * | 2004-02-13 | 2006-12-06 | Neuromolecular Inc. | Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders |
| AU2005277134A1 (en) * | 2004-08-24 | 2006-03-02 | Janssen Pharmaceutica N.V. | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| US20070191460A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis |
-
2007
- 2007-05-18 WO PCT/US2007/069250 patent/WO2007137164A2/en not_active Ceased
- 2007-05-18 US US11/750,579 patent/US20070293476A1/en not_active Abandoned
- 2007-05-18 TW TW096117855A patent/TW200812574A/zh unknown
- 2007-05-21 PE PE2007000616A patent/PE20080234A1/es not_active Application Discontinuation
- 2007-05-21 AR ARP070102201A patent/AR061066A1/es not_active Application Discontinuation
- 2007-05-22 CL CL200701468A patent/CL2007001468A1/es unknown
- 2007-05-22 UY UY30360A patent/UY30360A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070293476A1 (en) | 2007-12-20 |
| AR061066A1 (es) | 2008-07-30 |
| WO2007137164A2 (en) | 2007-11-29 |
| UY30360A1 (es) | 2007-08-31 |
| WO2007137164A3 (en) | 2008-01-17 |
| CL2007001468A1 (es) | 2008-04-04 |
| TW200812574A (en) | 2008-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080234A1 (es) | Combinacion antiepileptica que comprende derivados de benzoheteroarilsulfamidas | |
| PE20060500A1 (es) | Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes | |
| EA201490489A1 (ru) | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 | |
| PE20081374A1 (es) | Combinacion que comprende un agente antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina | |
| ECSP088871A (es) | Derivados de triazolopirazina | |
| GT200600028A (es) | Compuestos y composiciones como inhibidores de proteina kinasa | |
| DK1697370T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
| CR10243A (es) | "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos" | |
| EA200601648A1 (ru) | Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы | |
| DOP2003000566A (es) | Cicloalcanindoles con sustitución con fluor, composiciones que contienen estos compuestos y metodos de preparación para un medicamento | |
| DOP2001000170A (es) | Derivados de tiofeno utiles como agentes anticancesoros | |
| MA30765B1 (fr) | Derives innovants du thiophene | |
| ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
| PE20071251A1 (es) | Derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
| AR071959A1 (es) | Derivado de benceno o tiofeno y su uso como inhibidor de vap-1 | |
| ECSP055582A (es) | Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor | |
| CR8498A (es) | Derivados de prostaglandinas | |
| UY27774A1 (es) | Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona | |
| NI200900071A (es) | Compuestos de pirozolina y su uso y composiciones farmacéuticas. pc 33496a. | |
| PE20081781A1 (es) | Agonistas de adrenoreceptores alfa2c funcionalmente selectivos | |
| AR070025A1 (es) | Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica | |
| ECSP088967A (es) | Agonistas del receptor muscarínico que son efectivos en el tratamiento del dolor, la enfermedad de alzheimer y la esquizofrenia | |
| UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso | |
| AR082155A1 (es) | Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido | |
| AR059741A1 (es) | Formulaciones farmaceuticas liquidas y semisolidas y procedimientos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |